JUL 22, 2019 2:28 PM PDT

Understanding osteosarcoma in kids and dogs

New research published in the Nature journal, Communications Biology, shows evidence for a comparative study that scientists could use to improve treatment options. The study focuses on osteosarcoma (OS), an aggressive type of cancer that produces immature bone. It is the most common type of cancer that arises in bones, and although it is relatively rare (only about 1,000 new cases are diagnosed yearly), it usually affects children and those under the age of 25. Interestingly, it is also the most commonly-diagnosed primary bone tumor in dogs, affecting over 25,000 dogs annually.

"While osteosarcoma (OS) is rare in children, it is all too common in many dog breeds, which makes it a prime candidate for the kind of comparative cancer biology studies that could enhance drug development for both children and our canine friends," said senior author Will Hendricks, Ph.D., an Assistant Professor in TGen's Integrated Cancer Genomics Division.

The research comes from Tufts University and the Translational Genomics Research Institute (TGen), which is an affiliate of City of Hope. Perhaps due to its uncommonness, the disease has not seen any noteworthy medical advancements in the last thirty years; the authors hope their findings regarding the genetic similarities of osteosarcoma in canines and children will lead to new breakthroughs.

The need for such breakthrough is urgent, say the authors. Although treatment can prolong a patient’s life after diagnosis, approximately 30% of children diagnosed with OS die from metastatic tumors within 5 years; with dogs over 90% die within 2 years.

Upon analyzing the genomes of dogs and children, the researchers discovered that canine OS is similar to human OS in characteristics such as low mutation rates, structural complexity, altered cellular pathways. They also observed recurrent and potentially cancer-causing mutations in two different genes called SETD2 and DMD, both in canine osteosarcoma.

"These findings set the stage for understanding OS development in dogs and humans, and establish genomic contexts for future comparative analyses," said senior author Cheryl A. London, DVM, Ph.D., the Anne Engen and Dusty Professor in Comparative Oncology at Cummings School of Veterinary Medicine at Tufts University.

New research suggests the potential of a comparative study of canines and children with osteosarcoma. Photo: Pixabay

Contributing author Dr. Jeffrey Trent adds, "Leveraging the similarities between the human and canine forms of OS adds greatly to our understanding of how this aggressive cancer develops and spreads. More importantly, it provides an opportunity to develop therapies that make a difference in the lives of children and pets.”

Sources: Science Daily, Communications Biology

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
MAR 22, 2020
Cancer
MAR 22, 2020
What is "Shotgun ion mobility mass spectrometry sequencing"?
Research published recently in Nature Communications highlights a new method of mapping an essential family of polysacch ...
MAR 18, 2020
Drug Discovery & Development
MAR 18, 2020
Drug Could Effectively Treat a Lethal Blood Cancer
A pricey drug, called tyrosine kinase inhibitor (TKI), is used to continuously treat the blood cancer Chronic Myeloid Le ...
APR 14, 2020
Immunology
APR 14, 2020
Immunotherapy Shows Promise, Destroys Metastatic Brain Tumors
Lung cancer is the leading cause of death in both men and women in the U.S., with smokers bearing an elevated risk of th ...
APR 16, 2020
Cancer
APR 16, 2020
The Unseen Barriers Surrounding Pancreatic Cancer
Pancreatic cancer is one of the deadliest cancers in the world. With a poor five year prognosis and lack of effective tr ...
APR 18, 2020
Cancer
APR 18, 2020
A New Double Threat Against Skin Cancer
Skin cancer is one of the most common cancers in America.  One of the most aggressive forms of cancer is melanoma, ...
MAY 14, 2020
Clinical & Molecular DX
MAY 14, 2020
New Tech Has Its AI on Brain Tumors
  A collaboration across 29 research and healthcare agencies is putting together the world’s largest brain tu ...
Loading Comments...